U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 075432

Expand all

DOXAZOSIN MESYLATE (DOXAZOSIN MESYLATE)
EQ 1MG BASE
Marketing Status: Discontinued
Active Ingredient: DOXAZOSIN MESYLATE
Proprietary Name: DOXAZOSIN MESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 1MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A075432
Product Number: 001
Approval Date: Oct 18, 2000
Applicant Holder Full Name: ANI PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
DOXAZOSIN MESYLATE (DOXAZOSIN MESYLATE)
EQ 2MG BASE
Marketing Status: Discontinued
Active Ingredient: DOXAZOSIN MESYLATE
Proprietary Name: DOXAZOSIN MESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A075432
Product Number: 002
Approval Date: Oct 18, 2000
Applicant Holder Full Name: ANI PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
DOXAZOSIN MESYLATE (DOXAZOSIN MESYLATE)
EQ 4MG BASE
Marketing Status: Discontinued
Active Ingredient: DOXAZOSIN MESYLATE
Proprietary Name: DOXAZOSIN MESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 4MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A075432
Product Number: 003
Approval Date: Oct 18, 2000
Applicant Holder Full Name: ANI PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
DOXAZOSIN MESYLATE (DOXAZOSIN MESYLATE)
EQ 8MG BASE
Marketing Status: Discontinued
Active Ingredient: DOXAZOSIN MESYLATE
Proprietary Name: DOXAZOSIN MESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 8MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A075432
Product Number: 004
Approval Date: Oct 18, 2000
Applicant Holder Full Name: ANI PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top